Professor Yvonne Perrie

Head Of Institute

Strathclyde Institute of Pharmacy and Biomedical Sciences


Personal statement

My current position is Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland. In 1998 I gained my PhD from the University of London investigating the role of liposomes for DNA vaccines and drug delivery. I then worked within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology before moving into Academia to set up my own research group. I joined Aston University in 2000 and was appointed Professor in Drug Delivery in 2007. In 2016, I moved to the University of Strathclyde as Professor in Drug Delivery as part of the Global Talent Appointment Programme where I continue to develop and advance my research strategies.

My research is multi-disciplinary and focuses on developing drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. I am an internationally recognised expert in the field of liposomes and particulate drug delivery research. My laboratory is fully equipped to manufacture and analyze a wide range of nanoparticles, including a suite of microfluidic systems that will provide the underpinning support for this project. I maintain a steady funding stream to support my research team through various sources, including Government Research Councils, European Framework Funding, Industrial Partners, and Charities.

My research and academic leadership has been recognised via a range of fellowships and awards including the Royal Pharmaceutical Society Harrison Memorial Medal (2019),  50th Anniversary Chair in Drug Delivery (2016), membership of the Controlled Release Society College of Fellows (2015), Fellow of the Royal Pharmaceutical Society (2014), Fellow of the Royal Society of Biology (2012), Eminent Fellow of the Academy of Pharmaceutical Sciences (2012), the Royal Pharmaceutical Society Pharmaceutical Scientist of the Year (2012), the British Science Festival Collaboration in Formulation Award (2011) and the Royal Pharmaceutical Society Science Conference Medal (2007).

Back to staff profile


Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy
Oluwasanmi Adeolu, Lindsay Sarah, Curtis Anthony, Perrie Yvonne, Hoskins Clare
International Journal of Pharmaceutics Vol 644 (2023)
Physicochemical characterisation of poly(A) lipid nanoparticles : effect of cryoprotectant and temperature storage conditions
Abdulrahman Rand, Davidson Callum G, Perrie Yvonne, Treacher Kevin, Vasey Catherine, Capomaccio Robin, Rattray Zahra
European Platform for Technology Network on Nanomedicine 2023 Meeting (2023)
Go with the flow- High resolution lipid nanoparticle metrology
Davidson Callum G, Abdulrahman Rand, Punnabhum Panida, Perrie Yvonne, Rattray Zahra
European Platform for Technology Network on Nanomedicine 2023 Meeting (2023)
Evaluation of the critical quality attributes of lipid nanoparticles stored under different conditions
Abdulrahman Rand, Davidson Callum, Perrie Yvonne, Treacher Kevin, Vasey Catherine, Capomaccio Robin, Rattray Zahra
UKICRS symposium 2023 (2023)
The development of a novel pipeline for polymeric nanoparticle characterization following incubation under shear flow conditions
Daramy Karim, Punnabhum Panida, Perrie Yvonne, Rattray Zahra
National Physical Laboratory PGI conference: Postgraduate Institute for Measurement Science Symposium 2023 (2023)
Evaluating the impact of experimental shear flow parameters on nanoparticle protein corona formation
Daramy Karim, Punnabhum Panida, Hussain Muattaz Yassein Hussain, Minelli Caterina, Pei Yiwen, Rattray Nicholas, Perrie Yvonne, Rattray Zahra

More publications

Back to staff profile

Professional Activities

Enhancing the delivery of next generation RNA therapies through formulation design
Developing the next generation of lipid nanoparticles
Microfactories for nanoparticles: from the lab to our arm
Microfluidic manufacturing of LNPs for RNA delivery
mRNA-LNPs Vaccine Efficacy – is biological sex in experimental design important?
Manufacture of LNPs for RNA delivery: considerations from payload to process

More professional activities


Process Development and Stability of the RALA Peptide for mRNA Vaccines
Perrie, Yvonne (Principal Investigator)
01-Jan-2023 - 31-Jan-2025
Vax2muc Next Generation Vaccines Against Gastrointestinal Mucosal Pathogens, Using Helicobacter Pylori As Model Pathogen (Horizon Europe-Hlth-22-Disease)
Perrie, Yvonne (Principal Investigator)
01-Jan-2023 - 30-Jan-2028
Optimising hit-to-lead ratio for high-throughput screening of Lipid Nanoparticles for the delivery of mRNA (Researcher in Residence)
Perrie, Yvonne (Principal Investigator)
01-Jan-2023 - 30-Jan-2026
TargoPep: a cell selective delivery platform for therapeutic payloads (Follow on Fund)
Burley, Glenn (Principal Investigator) MacKay, Simon (Co-investigator) Perrie, Yvonne (Co-investigator) McWhinnie, Fergus (Research Co-investigator)
01-Jan-2023 - 31-Jan-2024
ICDDC - Interacellular Drug Delivery Centre
Perrie, Yvonne (Principal Investigator) Coxon, Geoffrey (Co-investigator)
01-Jan-2023 - 31-Jan-2026
NISV - Non Ionic Surfactant Vesicles
Roberts, Craig (Principal Investigator) Perrie, Yvonne (Co-investigator) Woods, Stuart (Research Co-investigator)
01-Jan-2022 - 27-Jan-2024

More projects

Back to staff profile


Professor Yvonne Perrie
Head Of Institute
Strathclyde Institute of Pharmacy and Biomedical Sciences

Tel: 548 2244